SR-89 THERAPY - STRONTIUM KINETICS IN DISSEMINATED CARCINOMA OF THE PROSTATE

被引：207
|
作者：
BLAKE, GM
ZIVANOVIC, MA
MCEWAN, AJ
ACKERY, DM
机构：
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1986年 / 12卷 / 09期
关键词：
D O I：
10.1007/BF00254749
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：447 / 454
页数：8
相关论文
共 50 条
  • [1] SR-89 THERAPY - STRONTIUM PLASMA-CLEARANCE IN DISSEMINATED PROSTATIC-CARCINOMA
    BLAKE, GM
    WOOD, JF
    WOOD, PJ
    ZIVANOVIC, MA
    LEWINGTON, VJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1989, 15 (01): : 49 - 54
  • [2] SR-89 RADIONUCLIDE THERAPY IN DISSEMINATED PROSTATIC-CARCINOMA
    BLAKE, GM
    MCEWAN, AJ
    ZIVANOVIC, MA
    BUCHANAN, RB
    ACKERY, DM
    KANIS, JA
    BONE, 1987, 8 (01) : 47 - 47
  • [3] SR-89 THERAPY - STRONTIUM KINETICS IN METASTATIC BONE-DISEASE
    BLAKE, GM
    ZIVANOVIC, MA
    MCEWAN, AJ
    ACKERY, DM
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 1030 - 1030
  • [4] SR-89 THERAPY - STRONTIUM KINETICS AND DOSIMETRY IN 2 PATIENTS TREATED FOR METASTASIZING OSTEOSARCOMA
    BLAKE, GM
    ZIVANOVIC, MA
    MCEWAN, AJ
    CONDON, BR
    ACKERY, DM
    BRITISH JOURNAL OF RADIOLOGY, 1987, 60 (711): : 253 - 259
  • [5] SR-89 THERAPY OF BONE METASTASES OF CARCINOMA OF THE PROSTATIC GLAND
    CORRENS, HJ
    MEBEL, M
    BUCHALI, K
    SCHNORR, D
    SEIDEL, C
    MITTERLECHNER, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1979, 4 (01): : 33 - 35
  • [6] THERAPY WITH SR-89 IN BONE METASTASES IN CARCINOMA OF THE PROSTATE - RESULTS OF A DOUBLE-BLIND-STUDY
    BUCHALI, K
    CORRENS, HJ
    SCHURER, M
    LIPS, H
    SYDOW, K
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1988, 43 (22): : 1981 - 1983
  • [7] DISSEMINATED INTRAVASCULAR COAGULATION IN A PATIENT WITH METASTATIC PROSTATE-CANCER - FATAL OUTCOME FOLLOWING SR-89 THERAPY
    LEONG, C
    MCKENZIE, MR
    COUPLAND, DB
    GASCOYNE, RD
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (10) : 1662 - 1664
  • [8] SR-89 THERAPY FOR SKELETAL METASTASES
    LAING, AH
    BRITISH JOURNAL OF RADIOLOGY, 1987, 60 (715): : 732 - 732
  • [9] Strontium-89 (Sr-89) does not add to the toxicity of adriamycin in the treatment of patients (Pts) with androgen independent (AI) prostate carcinoma (PC).
    Podoloff, DA
    Delpassand, ES
    Tu, S
    Jones, T
    Amato, R
    Ellerhorst, J
    Kilborne, R
    Broussard, WF
    Logothetis, C
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 119 - 119
  • [10] SR-89 IN METASTATIC PROSTATE-CANCER
    PORTER, AT
    VAISHAMPAYAN, N
    UROLOGY, 1994, 44 (6A) : 75 - 80
12345